Search

everythinglearnresearchcommunity

for

Search:↓

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

The vitamin D receptor is crucial for bone health and affects various body systems, with mutations potentially leading to disease.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Stress and emotional factors can worsen skin conditions by affecting the immune system.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Hypothyroidism in dogs is usually caused by immune system issues or gland atrophy, affects middle-aged purebreds most, and is treatable with medication.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

Toxic shock syndrome is caused by a complex interaction of bacterial toxins and the immune system, and understanding this can help improve diagnosis and treatment.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Pregnancy can cause symptoms similar to rheumatic diseases, making diagnosis difficult, and affects various body systems, requiring careful distinction between normal changes and serious conditions.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Cannabinoids may help treat various skin conditions.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Systemic lupus erythematosus is a chronic disease causing inflammation and various symptoms, mainly in young women, treated with anti-inflammatory and immunosuppressive drugs.

Hair splitting and nail detachment are linked conditions.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.